Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

VirnetX Holding (VHC) Research & Development (2016 - 2025)

VirnetX Holding (VHC) has disclosed Research & Development for 10 consecutive years, with $2.0 million as the latest value for Q4 2025.

  • Quarterly Research & Development fell 14.09% to $2.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.7 million through Dec 2025, down 6.36% year-over-year, with the annual reading at $5.7 million for FY2025, 6.36% down from the prior year.
  • Research & Development hit $2.0 million in Q4 2025 for VirnetX Holding, up from $1.1 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $4.8 million in Q2 2023 to a low of $1.1 million in Q3 2025.
  • Historically, Research & Development has averaged $1.7 million across 5 years, with a median of $1.2 million in 2022.
  • Biggest five-year swings in Research & Development: soared 278.88% in 2023 and later crashed 74.28% in 2024.
  • Year by year, Research & Development stood at $2.1 million in 2021, then rose by 27.44% to $2.7 million in 2022, then dropped by 12.41% to $2.4 million in 2023, then decreased by 0.04% to $2.4 million in 2024, then decreased by 14.09% to $2.0 million in 2025.
  • Business Quant data shows Research & Development for VHC at $2.0 million in Q4 2025, $1.1 million in Q3 2025, and $1.2 million in Q2 2025.